CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 162924-163062 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03","sourcedb":"CORD-19","sourceid":"3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03","text":"Several new compounds have recently entered clinical use that show improved tolerability profile or activity against drug resistant virus.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1284","span":{"begin":0,"end":138},"obj":"Sentence"},{"id":"T68538","span":{"begin":0,"end":138},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T1284","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T68538","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T148","span":{"begin":0,"end":138},"obj":"Sentence"}],"attributes":[{"subj":"T148","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T139","span":{"begin":117,"end":131},"obj":"Phenotype"}],"attributes":[{"id":"A139","pred":"hp_id","subj":"T139","obj":"http://purl.obolibrary.org/obo/HP_0020174"},{"subj":"T139","pred":"source","obj":"CORD-19-PD-HP"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93ec9b","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ec93a4"},{"id":"CORD-19-PD-HP","color":"#93beec"}]}]}}